Market size, growth to 2033 and clinical trials, side by side.
Germany is the bigger Oncology Nutrition market: $77 Mn against $55 Mn in 2023, about 1.4 times as large.
Germany grows faster: 5.5% a year, against 5.3%.
Clinical research: 44 active trials in the UK, 44 in Germany.
| Measure | ||
|---|---|---|
| Market size, 2023 | $55 Mn | $77 Mn |
| Market size, 2033 projected | $92 Mn | $131 Mn |
| Growth a year (CAGR) | 5.3% | 5.5% |
| Money added, 2023–2033 | $37 Mn | $54 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $0.79 | $0.92 |
| Active clinical trials | 44 | 44 |
| Full report | UK report | Germany report |
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Germany is the bigger Oncology Nutrition market: $77 Mn against $55 Mn in 2023, about 1.4 times as large.
Germany grows faster: 5.5% a year, against 5.3%.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.